Hologic, Inc.

Hologic, Inc. | May 03, 2016

A new cervical cancer screening study demonstrates that Pap+HPV Together™ (co-testing) remains the most effective strategy for detecting high-grade cervical lesions1,2, Hologic, Inc. (Nasdaq: HOLX) announced today. The study, published this month in Cancer Cytopathology, a peer-reviewed journal of the American Cancer Society, also showed no significant difference between the sensitivities of the Pap and HPV tests when either was used alone as a primary screening method....

Hologic, Inc. | May 02, 2016

While nearly three-quarters of Americans (71%) are aware of the effects that osteoporosis can have on their health, only about half report taking any steps to prevent it,1 according to the results of a new survey announced today by Hologic (Nasdaq: HOLX). To mark the start of National Osteoporosis Month, Hologic is raising awareness of this major threat to women's health, which affects nearly 56 million Americans....

Hologic, Inc. | March 02, 2016

Hologic, Inc. (Nasdaq: HOLX) announced today the European launch of the CE-marked Affirm™ prone biopsy system — the first dedicated prone biopsy system capable of both 2D and 3D™ imaging-guided breast biopsies....

EHRIntelligence | January 16, 2020

Eighty-four percent of EHR users are dissatisfied with the technical service and basic software account support from current EHR and HIT vendors, according to a 2020 Black Book Research survey. Since the HITECH Act was signed into law in 2009, EHRs have not only been more prevalent, but they have continued to change and evolve. However, technical service from EHR vendors hasn’t kept up with the constant change, according to high-level hospital tech managers. Healthcare software support is ...